bioRxivMicrobiology
SARS-CoV-2 neutralizing human antibodies protect against lower respiratory tract disease in a hamster model
B. L. Haagmans, D. Noack, N. M. A. Okba, W. LI, C. Wang, T. Bestebroer, R. de Vries, S. Herfst, D. de Meulder, P. van Run, M. M. Lamers, B. Rijnders, C. Rokx, F. J. M. van Kuppeveld, F. Grosveld, D. Drabek, C. GeurtsvanKessel, M. Koopmans, B. J. Bosch, T. Kuiken, B. Rockx
Abstract
Effective clinical intervention strategies for COVID-19 are urgently needed. Although several clinical trials have evaluated the use of convalescent plasma containing virus-neutralizing antibodies, the effectiveness has not been proven. We show that hamsters treated with a high dose of human convalescent plasma or a monoclonal antibody were protected against weight loss showing reduced pneumonia and pulmonary virus replication compared to control animals. However, a ten-fold lower dose of convalescent plasma showed no protective effect. Thus, variable and relatively low levels of virus neutralizing antibodies in convalescent plasma may limit their use for effective antiviral therapy, favouring concentrated, purified (monoclonal) antibodies.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Highly-Neutralizing COVID-19-Convalescent-Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters.
Y. Takamatsu, M. Imai, … H. Mitsuya·bioRxiv·Jun 29, 2021
- Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
r. cross, A. N. Prasad, … T. W. Geisbert·bioRxiv·Oct 14, 2020
- A SARS-CoV-2 neutralizing antibody protects from lung pathology in a COVID-19 hamster model
J. Kreye, S. M. Reincke, … N. Osterrieder·bioRxiv·Aug 15, 2020
- A potent SARS-CoV-2 neutralizing human monoclonal antibody that reduces viral burden and disease severity in Syrian hamsters
A. Fagre, J. Manhard, … T. Schountz·bioRxiv·Sep 25, 2020
- Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation
K. K. A. Van Rompay, K. J. Olstad, … J. R. Reader·bioRxiv·Sep 1, 2021
- Potent neutralizing anti-SARS-CoV-2 human antibodies cure infection with SARS-CoV-2 variants in hamster model
M. Imbrechts, W. Maes, … N. Geukens·bioRxiv·Nov 25, 2021